| Product NDC: | 23635-581 |
| Proprietary Name: | Roxicodone |
| Non Proprietary Name: | oxycodone hydrochloride |
| Active Ingredient(s): | 15 mg/1 & nbsp; oxycodone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 23635-581 |
| Labeler Name: | Mallinckrodt, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021011 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000831 |
| Package NDC: | 23635-581-10 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (23635-581-10) |
| NDC Code | 23635-581-10 |
| Proprietary Name | Roxicodone |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (23635-581-10) |
| Product NDC | 23635-581 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxycodone hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20000831 |
| Marketing Category Name | NDA |
| Labeler Name | Mallinckrodt, Inc |
| Substance Name | OXYCODONE HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |